1. Home
  2. NLOP vs NERV Comparison

NLOP vs NERV Comparison

Compare NLOP & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Net Lease Office Properties of Beneficial Interest

NLOP

Net Lease Office Properties of Beneficial Interest

HOLD

Current Price

$9.64

Market Cap

144.4M

Sector

N/A

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$2.30

Market Cap

166.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NLOP
NERV
Founded
N/A
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.4M
166.4M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
NLOP
NERV
Price
$9.64
$2.30
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $10.33
AVG Volume (30 Days)
★ 142.7K
105.4K
Earning Date
11-06-2026
11-04-2026
Dividend Yield
★ 3.50%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.27
N/A
Revenue
★ $118,915,000.00
$41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.67
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$9.48
$2.24
52 Week High
$30.26
$8.80

Technical Indicators

Market Signals
Indicator
NLOP
NERV
Relative Strength Index (RSI) 32.94 27.35
Support Level $9.50 N/A
Resistance Level $12.19 $5.69
Average True Range (ATR) 0.17 0.26
MACD 0.05 -0.02
Stochastic Oscillator 35.37 4.83

Price Performance

Historical Comparison
NLOP
NERV

About NLOP Net Lease Office Properties of Beneficial Interest

Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns, operates, and finances a diversified portfolio of office properties mainly leased to corporate tenants on a single-tenant, net-lease basis. The company operates as a single operating and reportable segment focused on owning and managing office properties that generate revenue mainly from long-term lease agreements with tenants.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: